|
|||||
|
|
The orthomolecular treatment of cancer. II. Clinical trial of high-dose ascorbic acid supplements in advanced human cancer |
|
| Authors: | E Cameron A Campbell |
| Institution: | 1. Department of Clinical Research, Vale of Leven District General Hospital, Dunbartonshire; Department of Medicine, Hairmyres Hospital, LanarkshireScotland;2. Institute of Orthomolecular Medicine, Menio Park, Calif.U.S.A. |
| Abstract: | This communication reports the clinical response of fifty consecutive advanced cancer patients to the continuous administration of large doses of ascorbic acid. It concludes that this simple and safe form of medication is of definite value in the palliation of terminal cancer. The findings suggest that it should be employed as a standard supportive measure to reinforce established methods of treatment in the general management of earlier and more favorable cases. |
| Keywords: | AA ascorbic acid ESR erythrocyte sedimentation rate GSR ground substance depolymerization residues from tumor stroma PHI physiological hyaluronidase inhibitor |
| 本文献已被 ScienceDirect 等数据库收录！ | |